Technologies - Momentum Biotechnologies

We offer a powerful portfolio of proteomic and chemoproteomic technologies to support drug discovery and research efforts.

Developed by OmicScouts, A Momentum Biotechnologies Company, this flexible and scalable assay suite enables researchers to comprehensively characterize protein properties across a range of contexts. Most technologies can be applied to multiple stages of the drug discovery and development pipeline, and all can be further customized to address specific experimental needs, such as increased throughput, challenging sample types, etc.

ProteomeScout™
Deep and rapid proteome profiling
PlasmaScout™
Clinical proteomics of plasma and serum proteins
QuantScout™
Targeted quantification of relevant proteoforms with maximum accuracy
TurnoverScout™
Global profiling of protein synthesis and degradation
Protein Turnover Atlas™
On-demand access to protein turnover data
SignalingScout™
Proteome-wide phosphorylation profiling
UbiScout™
Profiling of ubiquitination sites
DecryptM
Concentration-resolved PTM profiling
TargetScout™
Versatile, robust, and scalable platform for compound pulldowns
PhotoTargetScout™
Photo-affinity labeling and identification of compound-binding proteins
KinomeScout™
Target profiling for kinases and other ATP-binding proteins
CysScout™
Profiling of reactive cysteines
SideScout™
Label-free target profiling with biophysical proteomics
NucleoBeads™
Identifying and characterizing functional inhibitors of DNA-binding proteins and transcription factors
SurfaceScout™
Profiling of cell surface proteomes